MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Digital Deals Gift
  • Editor’s Picks
  • SPECIAL SERIES
  • Special Coverage
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • Politics
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
    • America Essay Contest
  • China
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business & Economy
    • Companies
    • Economy
    • Markets
    • Real Estate
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • News
    • Aging
    • Fitness & Nutrition
    • Wellness
    • Traditional Wisdom
    • Mindset
SEARCH
  • EpochTV
  • US
  • Politics
  • Opinion
  • World
  • China
  • Hong Kong
  • Business
  • Markets
  • Bright
  • Health
  • Arts
  • Premium
  • Games
  • Sports
  • Livestream
  • More

molnupiravir

  • All About the Newest COVID Pills – Should You Take Them?
    All About the Newest COVID Pills – Should You Take Them?
    Pfizer's new antiviral pill Paxlovid is receiving high-profile attention - the vice president even took it when she contracted COVID. But a strange phenomenon is being reported by some of ...
    May 11, 2022BY Joseph Mercola
  • Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill
    Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill
    Merck & Co said on Wednesday it expects its 2022 sales to increase as much as 18 percent ...
    February 4, 2022BY Reuters
  • Merck Expects COVID-19 Pill Molnupiravir to Be Effective Against Omicron
    Merck Expects COVID-19 Pill Molnupiravir to Be Effective Against Omicron
    Merck's COVID-19 oral pill molnupiravir has a mechanism of action that can work against Omicron and any other ...
    January 12, 2022BY Reuters
  • Merck Authorizes Indian Pharma Company to Manufacture and Supply Affordable COVID-19 Pills
    Merck Authorizes Indian Pharma Company to Manufacture and Supply Affordable COVID-19 Pills
    Indian multinational pharmaceutical company Dr. Reddy’s Laboratories will be launching a generic version of Merck's COVID-19 oral antiviral ...
    January 5, 2022BY Naveen Athrappully
  • India Boosts Arsenal Against COVID-19 With Merck Pill, 2 More Vaccines
    India Boosts Arsenal Against COVID-19 With Merck Pill, 2 More Vaccines
    BENGALURU—India has approved Merck's COVID-19 pill and two more vaccines for emergency use as the world's second-most populous ...
    December 29, 2021BY Reuters
  • France Cancels Order for Merck’s COVID-19 Antiviral Drug
    France Cancels Order for Merck’s COVID-19 Antiviral Drug
    PARIS—France has canceled its order for Merck & Co.'s COVID-19 antiviral drug following disappointing trial data and hopes ...
    December 24, 2021BY Reuters
  • FDA Advisers Vote to Recommend Merck COVID-19 Pill for Emergency Use Authorization
    FDA Advisers Vote to Recommend Merck COVID-19 Pill for Emergency Use Authorization
    Outside advisers to the U.S. Food and Drug Administration (FDA) on Tuesday narrowly voted to recommend the agency ...
    November 30, 2021BY Mimi Nguyen Ly
  • WHO Says Seeks More Data From Merck on COVID-19 Anti-Viral, From Bharat on Vaccine
    WHO Says Seeks More Data From Merck on COVID-19 Anti-Viral, From Bharat on Vaccine
    GENEVA—The World Health Organization (WHO) said on Thursday that it was seeking further data from Merck on its ...
    October 29, 2021BY Reuters
  • Merck Asks EU Regulator to Authorize Pill That Treats COVID-19
    Merck Asks EU Regulator to Authorize Pill That Treats COVID-19
    AMSTERDAM—The pharmaceutical company Merck says it has asked the European Medicines Agency to authorize its COVID-19 antiviral treatment, ...
    October 25, 2021BY The Associated Press
TOP NEWS
  • Gov. Greg Abbott Says He’s ‘Livid’ He Was ‘Misled’ About Texas School Shooting Events
    1hr By Caden Pearson
    Gov. Greg Abbott Says He’s ‘Livid’ He Was ‘Misled’ About Texas School Shooting Events
  • Menstrual Irregularities, Uterus Shedding Cases Spike After COVID Vaccine Rollout: Peer-Reviewed Study
    2hr By Enrico Trigoso
    Menstrual Irregularities, Uterus Shedding Cases Spike After COVID Vaccine Rollout: Peer-Reviewed Study
  • ‘Not Valid or Lawful’: McCarthy Responds to Jan. 6 Panel Subpoena in Lengthy Letter
    2hr By Joseph Lord
    ‘Not Valid or Lawful’: McCarthy Responds to Jan. 6 Panel Subpoena in Lengthy Letter
  • Travel: A Cup of Tradition in Vienna
    2hr By Janna Graber, GoWorldTravel.com
    Travel: A Cup of Tradition in Vienna
  • Obamacare ‘Double Whammy’ to Hit Right Before Midterms
    3hr By Jack Phillips
    Obamacare ‘Double Whammy’ to Hit Right Before Midterms
  • Elon Musk: Recession ‘A Good Thing’, Bankruptcies ‘Need to Happen’
    4hr By Andrew Moran
    Elon Musk: Recession ‘A Good Thing’, Bankruptcies ‘Need to Happen’
  • ‘You Go to the Sound of Gunfire’: Retired Active Shooter Trainer and Border Patrol Special Agent
    4hr By Charlotte Cuthbertson
    ‘You Go to the Sound of Gunfire’: Retired Active Shooter Trainer and Border Patrol Special Agent
  • Elon Musk Says He ‘Strongly’ Believes in Second Amendment, Suggests ‘Special Permit’ Be Required for ‘Assault Rifles’
    4hr By Gary Bai
    Elon Musk Says He ‘Strongly’ Believes in Second Amendment, Suggests ‘Special Permit’ Be Required for ‘Assault Rifles’
  • Health Viewpoints: FDA Approves First COVID Treatment for Young Children Despite Alarming Risks
    4hr By Xiaoxu Sean Lin and Health 1+1
    Health Viewpoints: FDA Approves First COVID Treatment for Young Children Despite Alarming Risks
  • Prosecutors Urge Jurors to Convict Ex-Clinton Lawyer, Defense Claims Reasonable Doubt
    4hr By John Haughey and Zachary Stieber
    Prosecutors Urge Jurors to Convict Ex-Clinton Lawyer, Defense Claims Reasonable Doubt
The Epoch Times
Help Center subscribe newsletter Newsstands Epoch Shop Digital Deals Gift
  • Editor’s Picks
  • SPECIAL SERIES
  • Special Coverage
  • LATEST ARTICLES
You deserve to hear the truth.
  • Contact Editorial
  • Contact Customer Care
  • Advertise
  • Copyrights and Permissions
  • PR and Media Inquiries
  • Media Statements
  • About Us
  • RSS Feeds
  • Terms of Services
  • Privacy Policy
  • Copyright Policy
  • Data Disclaimer
  • Digital Newspaper
  • Our Story
  • Subscribe
  • Careers
36 COUNTRIES, 22 LANGUAGES
  • Bulgarian
  • English
  • Chinese
  • Spanish
  • Japanese
  • Korean
  • Indonesian
  • French
  • German
  • Italian
  • Portuguese
  • Swedish
  • Dutch
  • Russian
  • Ukrainian
  • Romanian
  • Czech
  • Slovak
  • Polish
  • Turkish
  • Persian
  • Vietnamese
DOWNLOAD OUR APP
iOS Android
  • US
    • US News
    • US Features
    • Politics
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
    • America Essay Contest
  • China
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business & Economy
    • Companies
    • Economy
    • Markets
    • Real Estate
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • News
    • Aging
    • Fitness & Nutrition
    • Wellness
    • Traditional Wisdom
    • Mindset
Copyright © 2000 - 2022
Back Top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Use. More informationI accept×